Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
125
datasets available to search
ShareScore release 0.9.0
Dataset results
125 results for “tumor marker”
PD-L1 is an IFNγ-independent maturation marker on tumor-associated macrophages and associates with good clinical outcome in human breast cancer
GEO Series GSE248288. Homo sapiens. 4 samples. Type: Expression profiling by high throughput sequencing.
Prostate cancer cancer-associated fibroblasts with stable markers post-androgen deprivation therapy associated with tumor progression and castration resistant prostate cancer
GEO Series GSE250189. Homo sapiens. 2 samples. Type: Expression profiling by high throughput sequencing.
Surface marker identification to capture live circulating tumor cells in metastatic triple negative breast cancer
GEO Series GSE295462. Homo sapiens. 47 samples. Type: Expression profiling by high throughput sequencing.
Identification of cold tumor induction–related markers in pancreatic cancer and the clinical implication of PCDH7
GEO Series GSE255873. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker
GEO Series GSE141383. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
Liquid Biopsy: Examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for molecular tumor markers
GEO Series GSE156554. Homo sapiens. 15 samples. Type: Expression profiling by high throughput sequencing.
CD169 is a marker of IFN-γ-stimulated inflammatory macrophages in brain tumor [EGFRviii]
GEO Series GSE201557. Mus musculus. 2 samples. Type: Expression profiling by high throughput sequencing.
Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.
ClinicalTrials.gov study NCT03115138. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Identification and Characterization of Molecular Markers in Musculoskeletal Tumors
ClinicalTrials.gov study NCT02199938. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Circulating Tumor DNA as Marker for Response to Antineoplastic Treatment of Metastatic Cancer (FLUIDO)
ClinicalTrials.gov study NCT04793061. IPD Sharing: NO. Countries: 1. Publications: 0.
Markers of Prognosis and Response to Therapy in Patients With Metastatic Brain Tumors Undergoing Stereotactic Radiosurgery (SRS)
ClinicalTrials.gov study NCT01908179. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tumor Markers in Lung Cancer: DCAMLK-1LK-1
ClinicalTrials.gov study NCT01578018. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Diagnostic Accuracy of Ultrasound and Tumors Markers in Diagnosis of Complex Ovarian Cysts
ClinicalTrials.gov study NCT07005089. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma
ClinicalTrials.gov study NCT03302884. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Preexisting Immunity Markers in Human Tumor Tissue Sample
ClinicalTrials.gov study NCT00568867. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
ClinicalTrials.gov study NCT05530759. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Use of 5-aminolevulinic Acid (ALA) as an Intraoperative Tumor Marker for Resection of Pediatric Central Nervous System (CNS) Tumors
ClinicalTrials.gov study NCT02050243. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell Carcinoma
ClinicalTrials.gov study NCT01063998. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4
ClinicalTrials.gov study NCT05088395. IPD Sharing: YES. Countries: 1. Publications: 0.
HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC
ClinicalTrials.gov study NCT03020342. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.